These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 33171815)

  • 1. RNA Secondary Structure as a First Step for Rational Design of the Oligonucleotides towards Inhibition of Influenza A Virus Replication.
    Szabat M; Lorent D; Czapik T; Tomaszewska M; Kierzek E; Kierzek R
    Pathogens; 2020 Nov; 9(11):. PubMed ID: 33171815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and Functional RNA Motifs of SARS-CoV-2 and Influenza A Virus as a Target of Viral Inhibitors.
    Szczesniak I; Baliga-Gil A; Jarmolowicz A; Soszynska-Jozwiak M; Kierzek E
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
    Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Secondary Structure Motifs of the Influenza A Virus as Targets for siRNA-Mediated RNA Interference.
    Piasecka J; Lenartowicz E; Soszynska-Jozwiak M; Szutkowska B; Kierzek R; Kierzek E
    Mol Ther Nucleic Acids; 2020 Mar; 19():627-642. PubMed ID: 31945726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular Colocalization of Influenza Viral RNA and Rab11A Is Dependent upon Microtubule Filaments.
    Nturibi E; Bhagwat AR; Coburn S; Myerburg MM; Lakdawala SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28724771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary structure of the segment 5 genomic RNA of influenza A virus and its application for designing antisense oligonucleotides.
    Michalak P; Soszynska-Jozwiak M; Biala E; Moss WN; Kesy J; Szutkowska B; Lenartowicz E; Kierzek R; Kierzek E
    Sci Rep; 2019 Mar; 9(1):3801. PubMed ID: 30846846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Nucleolar Protein LYAR Facilitates Ribonucleoprotein Assembly of Influenza A Virus.
    Yang C; Liu X; Gao Q; Cheng T; Xiao R; Ming F; Zhang S; Jin M; Chen H; Ma W; Zhou H
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense Oligonucleotides Targeting Influenza A Segment 8 Genomic RNA Inhibit Viral Replication.
    Lenartowicz E; Nogales A; Kierzek E; Kierzek R; Martínez-Sobrido L; Turner DH
    Nucleic Acid Ther; 2016 Oct; 26(5):277-285. PubMed ID: 27463680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and Functional Motifs in Influenza Virus RNAs.
    Ferhadian D; Contrant M; Printz-Schweigert A; Smyth RP; Paillart JC; Marquet R
    Front Microbiol; 2018; 9():559. PubMed ID: 29651275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zinc Finger-Containing Cellular Transcription Corepressor ZBTB25 Promotes Influenza Virus RNA Transcription and Is a Target for Zinc Ejector Drugs.
    Chen SC; Jeng KS; Lai MMC
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segment-specific kinetics of mRNA, cRNA and vRNA accumulation during influenza infection.
    Phan T; Fay EJ; Lee Z; Aron S; Hu WS; Langlois RA
    J Virol; 2021 Apr; 95(10):. PubMed ID: 33658346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza virus segment 5 (+)RNA - secondary structure and new targets for antiviral strategies.
    Soszynska-Jozwiak M; Michalak P; Moss WN; Kierzek R; Kesy J; Kierzek E
    Sci Rep; 2017 Nov; 7(1):15041. PubMed ID: 29118447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Nucleolar Protein, Ribosomal RNA Processing 1 Homolog B (RRP1B), Enhances the Recruitment of Cellular mRNA in Influenza Virus Transcription.
    Su WC; Hsu SF; Lee YY; Jeng KS; Lai MM
    J Virol; 2015 Nov; 89(22):11245-55. PubMed ID: 26311876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Type of Influenza A Virus-Derived Defective Interfering Particle with Nucleotide Substitutions in Its Genome.
    Kupke SY; Riedel D; Frensing T; Zmora P; Reichl U
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30463972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Y-Box-Binding Protein 3 (YBX3) Restricts Influenza A Virus by Interacting with Viral Ribonucleoprotein Complex and Imparing its Function.
    Qin Z; Qu X; Lei L; Xu L; Pan Z
    J Gen Virol; 2020 Apr; 101(4):385-398. PubMed ID: 32553055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of influenza A virus replication by RNA interference targeted against the PB1 subunit of the RNA polymerase gene.
    Li W; Yang X; Jiang Y; Wang B; Yang Y; Jiang Z; Li M
    Arch Virol; 2011 Nov; 156(11):1979-87. PubMed ID: 21837415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Short Chemically Modified dsRNA-Binding PNA (dbPNA) Inhibits Influenza Viral Replication by Targeting Viral RNA Panhandle Structure.
    Kesy J; Patil KM; Kumar SR; Shu Z; Yong HY; Zimmermann L; Ong AAL; Toh DK; Krishna MS; Yang L; Decout JL; Luo D; Prabakaran M; Chen G; Kierzek E
    Bioconjug Chem; 2019 Mar; 30(3):931-943. PubMed ID: 30721034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activity of double-stranded RNA-binding protein PACT against influenza A virus mediated via suppression of viral RNA polymerase.
    Chan CP; Yuen CK; Cheung PH; Fung SY; Lui PY; Chen H; Kok KH; Jin DY
    FASEB J; 2018 Aug; 32(8):4380-4393. PubMed ID: 29513570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of a High-Throughput Assay to Monitor Influenza A Virus RNA Transcription and Replication.
    Wang Z; Zhao F; Gao Q; Liu Z; Zhang Y; Li X; Li Y; Ma W; Deng T; Zhang Z; Cen S
    PLoS One; 2015; 10(7):e0133558. PubMed ID: 26196128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of influenza A nucleoprotein body domain residues essential for viral RNA expression expose antiviral target.
    Davis AM; Ramirez J; Newcomb LL
    Virol J; 2017 Feb; 14(1):22. PubMed ID: 28173821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.